1,078 results found

Protect value by framing any consideration of the use of IP in the context of a business's competitive advantages. In this article, we show how to protect value by framing any consideration of the use of IP...

On 14 November 2018 the UK Supreme Court (SC) handed down its decision in Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan and Actavis

AlixPartners' inaugural survey of beverage executives reveals an industry focused on driving productivity in the face of supply chain pressures, rising input and labor costs...

In a world where competition is fierce, hoteliers are now tasked with providing not only quality rooms, but also a first-rate food and beverage (F&B) offering to attract consumers...

Proteins are a class of macromolecules which carry out a wide range of functions. For example, proteins are essential for photosynthesis, producing energy from food, contracting muscle fibres and DNA replication,...

On 18 June 2012, the State Food and Drug Administration ("SFDA") issued new regulations entitled "Interim Working Procedure of Unannounced Inspections over Manufacturing Enterprises of Medical Devices" ("Procedure").

In April 2023, we published an alert in relation to two European Commission legislative proposals: new Regulation 2023/0131 and new Directive 2023/0132...

When discussing my profession, particularly with those outside of intellectual property, I often mention that I am involved with food related inventions.

The global food system is a massive and intricate network that supports lives and livelihoods everywhere in the world. But its complexity and size also lead to an enormous burden on the environment.

In order to place a new medicinal product on the market in Europe, it is necessary first to obtain a marketing authorisation.

David Hardstaff and John Binns of BCL Solicitors LLP discuss the regulatory landscape in the UK following the EFSA's decision to pause all novel foods evaluations for CBD products.

Parental Alcohol Misuse (PAM) remains a significant safeguarding concern across England. Tens of thousands of children live with a parent whose alcohol...

Hospices and other health and social care providers delivering palliative and end-of-life care could be exposed to medical malpractice claims. We clarify the risks and evaluate the role of insurance.

In R. (on the application of Kellogg Marketing and Sales Co (UK) Ltd) v Secretary of State for Health and Social Care [2022] EWHC 1710 (Admin) the High Court dismissed all four grounds of a ...

This update focuses on: the UK's fall in global rankings for pharmaceutical investment; the importance of managing IP risks carefully when investing in US life sciences...

In recent years, many of the world's biggest pharmaceutical companies have carved out and spun off their consumer health divisions in an effort to refocus on core strategic areas and free up cash for investment

Welcome to RPC Bites. Our aim in the next 2 minutes is to provide you with a flavour of some key legal, regulatory and commercial developments in the Food & Drink sector over the last fortnight…

The question as to whether an SPC can be obtained for a further use or new formulation of a previously approved drug has been the subject of much debate and speculation in recent years.